Many studies have associated high levels of ST6GAL1 expression with clinicopathological parameters such as advanced tumor grade, lymphovascular invasion, metastatic progression, and overall survival in different types of cancer [23,26,35]. This evidence concerns the gene ST6GAL1 and cancer.